These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11068750)

  • 21. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
    Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
    Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antigenic determinants on membranes and monocyte function].
    Torubarova NA; Baryshnikov AIu; Mambetova ChD; Ni AN
    Gematol Transfuziol; 1988 May; 33(5):34-8. PubMed ID: 2457536
    [No Abstract]   [Full Text] [Related]  

  • 23. Problems in the physiology of class I and class II MHC molecules, and of CD45.
    Fisher AG; Goff LK; Lightstone L; Marvel J; Mitchison NA; Poirier G; Stauss H; Zamoyska R
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():667-74. PubMed ID: 2534841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cell biology of antigen processing.
    Levine TP; Chain BM
    Crit Rev Biochem Mol Biol; 1991; 26(5-6):439-73. PubMed ID: 1722142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The major histocompatibility complex-restricted antigen receptor on T cells. IX. Role of accessory molecules in recognition of antigen plus isolated IA.
    Gay D; Coeshott C; Golde W; Kappler J; Marrack P
    J Immunol; 1986 Mar; 136(6):2026-32. PubMed ID: 3512708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
    Kovacsovics-Bankowski M; Rock KL
    Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptides bound to major histocompatibility complex molecules.
    Maffei A; Harris PE
    Peptides; 1998; 19(1):179-98. PubMed ID: 9437752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts.
    Markmann JF; Jacobson JD; Kiumura H; Choti MA; Hickey WF; Fox IJ; Silvers WK; Barker CF; Naji A
    Transplantation; 1989 Sep; 48(3):478-86. PubMed ID: 2571205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferative responses to allogeneic HLA class I peptides.
    Paraoan MT; Sells RA; Bakran A; Hammad A; Christmas SE
    Transplant Proc; 2001; 33(1-2):334-5. PubMed ID: 11266848
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulation of antigen presentation by acidic pH.
    Jensen PE
    J Exp Med; 1990 May; 171(5):1779-84. PubMed ID: 2332737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between antigen concentration, antigen internalization, and antigenic complexes: modeling insights into antigen processing and presentation.
    Singer DF; Linderman JJ
    J Cell Biol; 1990 Jul; 111(1):55-68. PubMed ID: 2365735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane Ia expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes.
    Norcross MA; Bentley DM; Margulies DH; Germain RN
    J Exp Med; 1984 Nov; 160(5):1316-37. PubMed ID: 6436430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Instillation of allogeneic lung antigen-presenting cells deficient in expression of major histocompatibility complex class I or II antigens have differential effects on local cellular and humoral immunity and on pathology in recipient murine lungs.
    Heidler KM; Baker K; Woods K; Schnizlein-Bick C; Cummings OW; Sidner R; Foresman B; Wilkes DS
    Am J Respir Cell Mol Biol; 2000 Oct; 23(4):499-505. PubMed ID: 11017915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of vaccinia virus expression vectors to investigate antigen processing and presentation.
    Wherry EJ; Rajagopal D; Eisenlohr LC
    Methods Mol Biol; 2001; 156():89-109. PubMed ID: 11068753
    [No Abstract]   [Full Text] [Related]  

  • 35. Variation of MHC II expression on canine lymphocytes with age.
    Holmes MA; Lunn DP
    Tissue Antigens; 1994 Mar; 43(3):179-83. PubMed ID: 7916497
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell surface expression of MHC molecules in glioma cells infected with herpes simplex virus type-1.
    Song GY; DeJong G; Jia W
    J Neuroimmunol; 1999 Jan; 93(1-2):1-7. PubMed ID: 10378863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen presentation: structural themes and functional variations.
    Braciale TJ; Braciale VL
    Immunol Today; 1991 Apr; 12(4):124-9. PubMed ID: 1711855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen presentation to cytotoxic T lymphocytes in vivo.
    Bevan MJ
    J Exp Med; 1995 Sep; 182(3):639-41. PubMed ID: 7650475
    [No Abstract]   [Full Text] [Related]  

  • 40. A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex.
    Mellins E; Kempin S; Smith L; Monji T; Pious D
    J Exp Med; 1991 Dec; 174(6):1607-15. PubMed ID: 1744588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.